New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.2518-0.0305 (-10.80%)
At close: 04:00PM EDT
0.2797 +0.03 (+11.08%)
After hours: 07:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 36.00M
Enterprise value -23.95M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)153.87
Price/book (mrq)0.59
Enterprise value/revenue -102.41
Enterprise value/EBITDA 0.50

Trading information

Stock price history

Beta (5Y monthly) 2.03
52-week change 3-86.94%
S&P500 52-week change 3-8.83%
52-week high 31.9700
52-week low 30.2080
50-day moving average 30.3064
200-day moving average 30.6073

Share statistics

Avg vol (3-month) 31.36M
Avg vol (10-day) 3674.43k
Shares outstanding 5125.26M
Implied shares outstanding 6N/A
Float 8124.68M
% held by insiders 10.46%
% held by institutions 133.42%
Shares short (30 May 2022) 43.52M
Short ratio (30 May 2022) 41.34
Short % of float (30 May 2022) 42.82%
Short % of shares outstanding (30 May 2022) 42.81%
Shares short (prior month 28 Apr 2022) 43.84M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-20,990.16%

Management effectiveness

Return on assets (ttm)-26.02%
Return on equity (ttm)-51.11%

Income statement

Revenue (ttm)233.88k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-35.56M
EBITDA -48.17M
Net income avi to common (ttm)-39.01M
Diluted EPS (ttm)-0.3120
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)86.12M
Total cash per share (mrq)0.69
Total debt (mrq)26.17M
Total debt/equity (mrq)42.79
Current ratio (mrq)5.85
Book value per share (mrq)0.49

Cash flow statement

Operating cash flow (ttm)-36.99M
Levered free cash flow (ttm)-31.46M